Delivery Order SPE2DB20D3103-SPE2DB24FM6D2
- Not listed
- This contract award is for the delivery of Doxorubicin Liposome 50mg/25ml vials to the U.S. Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,500.00 contract has a firm fixed price and an ultimate completion date of February 12, 2024. This is a delivery order contract without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,500.00 firm fixed-price delivery order is for the supply of Doxorubicin Liposome 50mg/25ml, a specialty medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Doxorubicin Liposome 20mg/10ml in 10ml vials, with a contract ceiling value of $1,922.10 and an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- This firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,353.51 and a period of performance ending on June 16, 2025. Amerisourcebergen Drug Corp supplies a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide through a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award is for a pharmaceutical supply delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $108,672.37 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to deliver a range of prescription medications, medical devices, and other healthcare-related supplies. The order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award is for a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $1,660.48 and an ultimate completion date of May 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical...
- This federal contract award is a delivery order with a firm fixed price of $21,501.64 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is not set aside and has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA, which provides a comprehensive global pharmaceutical...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,127.28 on January 29, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and utilizes no set-aside designation, indicating it was competitively awarded. This delivery order represents a task order issued under...
- This federal contract award is for a prime vendor pharmaceutical supply delivery order valued at $1,054.82 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of November 10, 2022 and is a firm fixed price delivery order. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The...
- This is a $1,194.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Medical Supply Chain for pharmaceutical products. The contract has an ultimate completion date of July 7, 2025 and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has held a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical since 2012, valued at up to $999,999,999.00....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM6D2Delivery Order
This federal contract award is for the delivery of Doxorubicin Liposome 50mg/25ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,500.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 9, 2024, with a completion date of February 12, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs globally. This specific delivery order is likely part of that broader IDC mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/9/24 |